These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12957636)

  • 1. Protonation equilibrium and lipophilicity of olamufloxacin (HSR-903), a newly synthesized fluoroquinolone antibacterial.
    Sun J; Sakai S; Tauchi Y; Deguchi Y; Cheng G; Chen J; Morimoto K
    Eur J Pharm Biopharm; 2003 Sep; 56(2):223-9. PubMed ID: 12957636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protonation equilibrium and lipophilicity of moxifloxacin.
    Langlois MH; Montagut M; Dubost JP; Grellet J; Saux MC
    J Pharm Biomed Anal; 2005 Feb; 37(2):389-93. PubMed ID: 15708683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium.
    Sun J; Sakai S; Tauchi Y; Deguchi Y; Chen J; Zhang R; Morimoto K
    Eur J Pharm Biopharm; 2002 Jul; 54(1):51-8. PubMed ID: 12084502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
    Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
    Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
    J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triprotic site-specific acid-base equilibria and related properties of fluoroquinolone antibacterials.
    Rusu A; Tóth G; Szőcs L; Kökösi J; Kraszni M; Gyéresi Á; Noszál B
    J Pharm Biomed Anal; 2012 Jul; 66():50-7. PubMed ID: 22464555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of protonation macro- and microconstants and octanol/water partition coefficient of the antiinflammatory drug niflumic acid.
    Takács-Novák K; Avdeef A; Box KJ; Podányi B; Szász G
    J Pharm Biomed Anal; 1994 Nov; 12(11):1369-77. PubMed ID: 7849133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice.
    Yoshizumi S; Takahashi Y; Murata M; Domon H; Furuya N; Ishii Y; Matsumoto T; Ohno A; Tateda K; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 2001 Jul; 48(1):137-40. PubMed ID: 11418525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
    Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
    Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds.
    Nurchi VM; Crisponi G; Lachowicz JI; Zoroddu MA; Peana M; Medici S; Veclani D; Tolazzi M; Melchior A
    Eur J Pharm Sci; 2016 Oct; 93():380-91. PubMed ID: 27586021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between the structures and physicochemical properties of chemotherapeutic fluoroquinolone agents].
    Szász G; Takácsné NK; Budváriné BZ; Hermecz I; Józan M; Lóre A; Noszál B
    Acta Pharm Hung; 1993 May; 63(3):105-14. PubMed ID: 8362651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on correlation between protonation and tautomerism and luminescence characteristics of quinolone].
    Du L; Jin W; Dong C; Liu C
    Guang Pu Xue Yu Guang Pu Fen Xi; 2001 Aug; 21(4):518-20. PubMed ID: 12945279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipophilicity of zwitterions and related species: a new insight.
    Mazák K; Kökösi J; Noszál B
    Eur J Pharm Sci; 2011 Sep; 44(1-2):68-73. PubMed ID: 21726635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility, lipophilicity and membrane permeability of some fluoroquinolone antimicrobials.
    Blokhina SV; Sharapova AV; Ol'khovich MV; Volkova ТV; Perlovich GL
    Eur J Pharm Sci; 2016 Oct; 93():29-37. PubMed ID: 27473309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the exposure and antibacterial activity of fluoroquinolones based on physicochemical properties.
    Völgyi G; Vizserálek G; Takács-Novák K; Avdeef A; Tam KY
    Eur J Pharm Sci; 2012 Aug; 47(1):21-7. PubMed ID: 22579663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical properties of lomefloxacin, levofloxacin, and moxifloxacin relevant to the biopharmaceutics classification system.
    Kłosińska-Szmurło E; Grudzień M; Betlejewska-Kielak K; Pluciński F; Biernacka J; Mazurek AP
    Acta Chim Slov; 2014; 61(4):827-34. PubMed ID: 25551723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR analysis and site-specific protonation constants of streptomycin.
    Orgován G; Noszál B
    J Pharm Biomed Anal; 2012 Feb; 59():78-82. PubMed ID: 22079046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coupling of drug protonation to the specific binding of aminoglycosides to the A site of 16 S rRNA: elucidation of the number of drug amino groups involved and their identities.
    Kaul M; Barbieri CM; Kerrigan JE; Pilch DS
    J Mol Biol; 2003 Mar; 326(5):1373-87. PubMed ID: 12595251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olamufloxacin. Hokuriku Seiyaku.
    Jiraskova N
    Curr Opin Investig Drugs; 2000 Sep; 1(1):31-4. PubMed ID: 11249592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH Dependence of the photocycle kinetics of the E46Q mutant of photoactive yellow protein: protonation equilibrium between I1 and I2 intermediates, chromophore deprotonation by hydroxyl uptake, and protonation relaxation of the dark state.
    Borucki B; Otto H; Joshi CP; Gasperi C; Cusanovich MA; Devanathan S; Tollin G; Heyn MP
    Biochemistry; 2003 Jul; 42(29):8780-90. PubMed ID: 12873139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.